Phenotypic and genotypic characterization of a tension-type headachepopulation

Section of Orofacial Pain and Jaw Function, Aarhus University0 个研究点目标入组 108 人开始时间: 2016年10月19日最近更新: 2020年11月3日

适应症

试验速览

暂无简介。

•TTH participants:
•Patients must fulfill the ICHD-3 criteria for either FETTH or CTTH
•Taking or will be taking mirtazapine for prophylaxis of TTH
•Between 18 and 65 years of age
•Fertile women must use adequate contraception (oral contraceptive pills, intrauterine devices or birth control implant)
•Participants must agree to participate in the study and sign informed consent
•Healthy participants
•Between 18 and 65 years of age
•Fertile women must use adequate contraception (oral contraceptive pills, intrauterine devices or birth control implant)
•Participants must agree to participate in the study and sign informed consent
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 108
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range

•No psychiatric or major medical conditions currently or in the past 12 months
•No concurrent headache, pain symptoms or diagnoses other than that of TTH
•Diagnosis of cancer presently or in the past 5 years
•Abuse of drugs including alcohol
•Diagnosis of Raynaud’s phenomenon
•Having gone through a sympathectomy procedure
•Diagnosis of cardiovascular disease
•Diagnosis of lung insufficiency, including bronchial asthma
•Diagnosis of diabetes mellitus
•Students who are currently taught by any of the people related to the project
•Participants who cannot follow the study protocol
•Participants who do not agree to comply with the requirements for participation in all sessions concerning times, food intake and physical activity.

发起方

Section of Orofacial Pain and Jaw Function, Aarhus University